Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1479 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

LIPITENSION : Interplay between dyslipidemia and hypertension

Dalal Jamshed J, Padmanabhan T. N. C., Jain Piyush, Patil Shiva, Vasnawala Hardik, Gulati Ashish

Year : 2012| Volume: 16| Issue : 2 | Page no: 240-245

   This article has been cited by
 
1 Metabolic-related markers and inflammatory factors as predictors of dyslipidemia among urban Han Chinese adults
Ying Lian,Lingling Xie,Yafei Liu,Fang Tang
Lipids in Health and Disease. 2019; 18(1)
[Pubmed]  [Google Scholar] [DOI]
2 Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
Xiaowei Yan,Yong Li,Yugang Dong,Yanhua Wu,Jihu Li,Rui Bian,Dayi Hu
Lipids in Health and Disease. 2019; 18(1)
[Pubmed]  [Google Scholar] [DOI]
3 Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta
Rea Ariyanti,Besral Besral
Journal of Lipids. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
4 Blood pressure control, glycemic control, and dyslipidemia among healthy adults in the Cape Coast metropolis, Ghana
Worlanyo Eric Gato,Samuel Acquah,Paul Nsiah,Samuel Tawiah Opoku,Bettye Appiah Apenteng,Benjamin Kwasi Johnson
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(1): 56
[Pubmed]  [Google Scholar] [DOI]
5 Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population
Marcela Segoviano-Mendoza,Manuel Cárdenas-de la Cruz,José Salas-Pacheco,Fernando Vázquez-Alaniz,Osmel La Llave-León,Francisco Castellanos-Juárez,Jazmín Méndez-Hernández,Marcelo Barraza-Salas,Ernesto Miranda-Morales,Oscar Arias-Carrión,Edna Méndez-Hernández
BMC Psychiatry. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
6 Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly
John S. Sampalis,Eliofotisti Psaradellis,Melissa Stutz,Jenaya Rickard,Emmanouil Rampakakis
Drugs in R&D. 2018; 18(4): 283
[Pubmed]  [Google Scholar] [DOI]
7 Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea
Jimin Lee,Sukhyang Lee
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2018; 38(11): 1095
[Pubmed]  [Google Scholar] [DOI]
8 Metabolomic characterization of hypertension and dyslipidemia
Chaofu Ke,Xiaohong Zhu,Yuxia Zhang,Yueping Shen
Metabolomics. 2018; 14(9)
[Pubmed]  [Google Scholar] [DOI]
9 Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat
Susana Rivera-Mancía,Eloisa Colín-Ramírez,Raúl Cartas-Rosado,Oscar Infante,Jesús Vargas-Barrón,Maite Vallejo
Medicine. 2018; 97(34): e11869
[Pubmed]  [Google Scholar] [DOI]
10 Glycemic effects of simvastatin: Where do we stand?
Nor Razida Razali,Hasniza Zaman Huri,Luqman Ibrahim,Shireene Ratna Vethakkan,Bashar Mudhaffar Abdullah
Brazilian Journal of Pharmaceutical Sciences. 2018; 54(1)
[Pubmed]  [Google Scholar] [DOI]
11 Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009–2016 in Lithuania
Sandra Kutkiene,Zaneta Petrulioniene,Aleksandras Laucevicius,Pranas Serpytis,Vytautas Kasiulevicius,Justina Staigyte,Akvile Saulyte,Emilija Petrulionyte,Urte Gargalskaite,Egle Skiauteryte,Gabija Matuzeviciene,Milda Kovaite,Egidija Rinkuniene
Lipids in Health and Disease. 2018; 17(1)
[Pubmed]  [Google Scholar] [DOI]
12 Protocol for a prospective longitudinal study of risk factors for hypertension incidence in a Mexico City population: the Tlalpan 2020 cohort
Eloisa Colín-Ramírez,Susana Rivera-Mancía,Oscar Infante-Vázquez,Raúl Cartas-Rosado,Jesús Vargas-Barrón,Magdalena Madero,Maite Vallejo
BMJ Open. 2017; 7(7): e016773
[Pubmed]  [Google Scholar] [DOI]
13 Eryptosis and oxidative damage in hypertensive and dyslipidemic patients
Carmen Elisa Pinzón-Díaz,José Víctor Calderón-Salinas,Margarita Marcela Rosas-Flores,Gerardo Hernández,Alicia López-Betancourt,Martha Angélica Quintanar-Escorza
Molecular and Cellular Biochemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
14 Atherogenic Risk Assessment among Persons Living in Rural Uganda
Clara Wekesa,Gershim Asiki,Ivan Kasamba,Laban Waswa,Steven J. Reynolds,Rebecca N. Nsubuga,Rob Newton,Anatoli Kamali
Journal of Tropical Medicine. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
15 Interactions of Six SNPs in ABCA1gene and Obesity in Low HDL-C Disease in Kazakh of China
Ming-hong Yao,Heng Guo,Jia He,Yi-zhong Yan,Ru-lin Ma,Yu-song Ding,Jing-yu Zhang,Jia-ming Liu,Mei Zhang,Shu-gang Li,Shang-zhi Xu,Qiang Niu,Jiao-long Ma,Shu-xia Guo
International Journal of Environmental Research and Public Health. 2016; 13(2): 176
[Pubmed]  [Google Scholar] [DOI]
16 Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications
Abeer A. ALrefai,Mona Salah El-din Habib,Rehab I. Yaseen,Mahmoud K. Gabr,Rabab M. Habeeb
Molecular and Cellular Biochemistry. 2016; 421(1-2): 103
[Pubmed]  [Google Scholar] [DOI]
17 The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania
Egidija Rinkuniene,Aleksandras Laucevicius,Žaneta Petrulioniene,Vilma Dženkeviciute,Sandra Kutkiene,Agne Skujaite,Vytautas Kasiulevicius
Clinical Lipidology. 2015; 10(3): 219
[Pubmed]  [Google Scholar] [DOI]

 

Read this article